Finance

Lists
Why is 002940 up 4.05%?
Dive Deeper
002940:SHE
Zhejiang Anglikang Pharmaceutical Co Ltd
CNÂ¥23.89
+4.05%
(+0.93) 1D
Oct 8, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002940...
Open
CNÂ¥23.18
High
CNÂ¥24.80
Low
CNÂ¥22.88
Mkt. cap
4.63B
Avg. vol.
9.81M
Volume
14.94M
Dividend
1.05%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jun 22, 2026
P/E ratio
42.72
52-wk high
CNÂ¥48.90
52-wk low
CNÂ¥22.22
EPS
CNÂ¥0.56
Shares outstanding
201.73M
No. of employees
1K
Open
CNÂ¥23.18
High
CNÂ¥24.80
Low
CNÂ¥22.88
Mkt. cap
4.63B
Avg. vol.
9.81M
Volume
14.94M
Dividend
1.05%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jun 22, 2026
P/E ratio
42.72
52-wk high
CNÂ¥48.90
52-wk low
CNÂ¥22.22
EPS
CNÂ¥0.56
Shares outstanding
201.73M
No. of employees
1K
News stories
From web sources and news partners
About Zhejiang Anglikang Pharmaceutical Co Ltd
CEO-
Employees1.24K
FoundedDec 30, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
330.81M
369.64M
340.16M
286.88M
Cost of goods sold
202.07M
221.21M
215.60M
165.79M
Cost of revenue
202.07M
221.21M
215.60M
165.79M
Research and development expenses
37.79M
22.18M
34.11M
30.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.63M
65.01M
61.98M
54.48M
Operating expense
104.52M
92.72M
94.14M
87.23M
Total operating expenses
306.59M
313.93M
309.73M
253.02M
Operating income
24.22M
55.71M
30.42M
33.86M
Other non operating income
-1.04M
692.58K
-2.27M
1.65M
EBT including unusual items
17.80M
67.76M
24.18M
48.96M
EBT excluding unusual items
21.92M
56.31M
27.92M
31.74M
Income tax expense
396.68K
11.54M
792.30K
5.46M
Effective tax rate
2.23%
17.03%
3.28%
11.16%
Other operating expenses
3.62M
3.29M
-95.92K
3.10M
Net income
11.76M
47.75M
17.65M
37.27M
Net profit margin
3.56%
12.92%
5.19%
12.99%
Earnings per share
-
-
-
-
Interest and investment income
3.40M
2.60M
2.78M
2.20M
Interest expense
-3.28M
-3.01M
-3.00M
-2.78M
Net interest expenses
120.15K
-403.65K
-224.39K
-575.41K
Depreciation and amortization charges
-
-
-
-
EBITDA
45.95M
74.90M
49.61M
52.67M
Gain or loss from assets sale
-53.31K
27.78K
-
-
AI content may include mistakes. Learn more
Google apps